🟢 Echo IQ Limited is trading 3% up today as investors refocus on US FDA growth story

Echo IQ Limited is trading 3% up today at $1.21, extending a short-term rebound after last week’s pullback as investors revisit the company’s US expansion narrative.

• The move appears tied to renewed interest in the company’s recent 510(k) FDA clearance for its EchoSolv AS platform and its associated US commercialisation potential.
• A June 16, 2026 hero note highlighted the platform as a key growth catalyst, which continues to drive investor sentiment during the current recovery in shares.
• The price action reflects a broader refocus on the company's ability to scale its diagnostic technology within the American healthcare market.